Hello friends and family;
In late January Mark was diagnosed with multiple myeloma, a cancer of the plasma cells found in bone marrow. He has responded very well to treatments thus far and we remain hopeful that a stem cell transplant later this fall will put his cancer into remission for an extended period. The cause or causes of myeloma remain unknown. Every year several thousand Canadians are diagnosed with myeloma, yet it remains a relatively unknown cancer. Although there is yet no cure, myeloma is treatable and the overall outlook for patients is improving steadily.
Myeloma Canada is a non-profit, charitable organization created by, and for people impacted by multiple myeloma. Exclusively devoted to the Canadian myeloma community, Myeloma Canada, in partnership with the Myeloma Canada Research Network, is dedicated to advancing the understanding, treatment and management of the disease and accelerating access to game-changing therapies for Canadians living with myeloma. Myeloma Canada has improved the lives of Canadians impacted by myeloma by accelerating access to better care through awareness, education, advocacy, community engagement and clinical research.
As a patient-driven, patient-focused grassroots organization, Myeloma Canada drives collaborative efforts to unify the voice of the community to effectively shape the Canadian treatment landscape with a committed focus on the improvement of patient outcomes by:
- Providing educational resources to patients, families and caregivers
- Increasing awareness of the disease and its effects on the lives of patients and their families
- Facilitating access to new therapies, treatment options and healthcare resources
- Advancing clinical research and promote access to new drug trials in Canada
- Empowering patients and caregivers through community engagement
Our team is raising money in support of Myeloma Canada by participating in the 5 km Multiple Myeloma March in Vancouver on October 20, 2018. Please join us in the walk if you are able.
By making a donation, you are helping to fund clinical research and to support advocacy for accelerated access to game-changing therapies for Canadian myeloma patients.
If you think this page contains objectionable content, please inform the system administrator.